MMSE and MoCA feasibility in Parkinson’s disease and dementia with Lewy bodies: A multicenter 1-year follow-up study
Objective: The aims of this study were to investigate which scale is best suited to assess cognition and more sensitive to cognitive decline over time…Modeling dementia with Lewy bodies using patient-derived neurons
Objective: To model Dementia with Lewy bodies (DLB) using neurons derived from patients clinically diagnosed with the disease. Background: A major challenge in neurodegenerative disease…Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis
Objective: To perform a systematic review of the studies on diagnostic accuracy in dementia with Lewy bodies (DLB) and to meta-analyse sensitivity, specificity and accuracy…Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach
Objective: The aim of our study is to understand the role of synaptic dysfunction in cognitive decline by comparing the whole proteome of Parkinson's disease…High frequency of mutations in the glucocerebrosidase (GBA) gene among Ashkenazi Jews with dementia with Lewy bodies
Objective: The objective of this study was to characterize, clinically and genetically, anAshkenazi Jewish cohort of patients diagnosed with DLB, looking for the association with…Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review
Objective: To systematically review the literature for evidence of an association between orthostatic hypotension (OH) and cognitive impairment (CI) in α-synucleinopathies and to discuss possible…α-synuclein in peripheral organs decreases in Lewy body disease complicated by Alzheimer’s disease
Objective: To examine whether the degree of α-synuclein (α-Syn) in the peripheral organs of patients with Lewy body disease (LBD: Parkinson's disease, dementia with Lewy…Single-subject FDG PET patterns and cognitive dysfunctions in Parkinson’s disease
Objective: To evaluate [18]FDG-PET single-subject perfusion patterns in Parkinson's disease (PD) patients and their relationship with cognitive dysfunction and progression during five years of follow-up.…Clusterin CSF levels in differential diagnosis of neurodegenerative disorders
Objective: To find a specific in vivo marker to improve a differential diagnosis between Parkinson´s disease and atypical Parkinsonian syndromes, especially early in the course…Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia
Objective: The objective of this study was the identification of biochemical markers of cognitive impairment in Parkinson's disease (PD) and dementia with Lewy bodies (DLB)…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.